Incidence of Treatment Delays among Patients with Diabetes: A Clinic-based Cross-sectional Descriptive Study in India.

Q3 Medicine

The Journal of the Association of Physicians of India Pub Date : 2025-09-01 DOI:10.59556/japi.73.1120

Shubhashree Patil, Bharat Saboo, Seema A Bagri, Priti Sanghavi, Tanuja Shah, Sybal Dbritto, Aashna Patil, Rohini S Gajare, Aparna G Muley, Ayaz Ansari, Mrinalini Singh, Charusheela Kolhe, Kinnary R Shah, Sanjyoti Khot, Pranjali Shah, Hardik Bambhania, Rukiya Shaikh, Seema Jashnani

{"title":"Incidence of Treatment Delays among Patients with Diabetes: A Clinic-based Cross-sectional Descriptive Study in India.","authors":"Shubhashree Patil, Bharat Saboo, Seema A Bagri, Priti Sanghavi, Tanuja Shah, Sybal Dbritto, Aashna Patil, Rohini S Gajare, Aparna G Muley, Ayaz Ansari, Mrinalini Singh, Charusheela Kolhe, Kinnary R Shah, Sanjyoti Khot, Pranjali Shah, Hardik Bambhania, Rukiya Shaikh, Seema Jashnani","doi":"10.59556/japi.73.1120","DOIUrl":null,"url":null,"abstract":"Background: Diabetes mellitus is a global epidemic, with an increasing number of undiagnosed individuals, particularly those with type 2 diabetes mellitus (T2DM). However, there is limited data on treatment delays among drug-naïve patients in India. The present study aimed to ascertain the incidence of treatment delay among drug-naïve patients and the sequence of alternate treatments sought since diagnosis.Materials and methods: This cross-sectional, multicentric, observational study was conducted across 10 primary and secondary care settings in Mumbai from October 2023 to April 2024. Adults of either gender, diagnosed with T2DM, who are drug-naïve, were included. Patient's demographic data, comorbidities, current medications, and medical history were recorded in an electronic case report form and analyzed.Results: Of the 625 patients enrolled, 591 completed the study. The mean age of the patients was 46.7 years. The proportion of male patients was 54.1%. Overall, 57% of patients had no treatment delays, while 43% experienced delays of ≥3 months. Patients with treatment delays of ≥3 months used alternative/traditional medicines (56.0%), with Ayurveda being preferred by 56.7% of these patients.Conclusion: The study indicated considerable treatment delays among drug-naïve patients in India.","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"73 9","pages":"e15-e20"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Association of Physicians of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59556/japi.73.1120","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Diabetes mellitus is a global epidemic, with an increasing number of undiagnosed individuals, particularly those with type 2 diabetes mellitus (T2DM). However, there is limited data on treatment delays among drug-naïve patients in India. The present study aimed to ascertain the incidence of treatment delay among drug-naïve patients and the sequence of alternate treatments sought since diagnosis.

Materials and methods: This cross-sectional, multicentric, observational study was conducted across 10 primary and secondary care settings in Mumbai from October 2023 to April 2024. Adults of either gender, diagnosed with T2DM, who are drug-naïve, were included. Patient's demographic data, comorbidities, current medications, and medical history were recorded in an electronic case report form and analyzed.

Results: Of the 625 patients enrolled, 591 completed the study. The mean age of the patients was 46.7 years. The proportion of male patients was 54.1%. Overall, 57% of patients had no treatment delays, while 43% experienced delays of ≥3 months. Patients with treatment delays of ≥3 months used alternative/traditional medicines (56.0%), with Ayurveda being preferred by 56.7% of these patients.

Conclusion: The study indicated considerable treatment delays among drug-naïve patients in India.

查看原文本刊更多论文

糖尿病患者治疗延误的发生率：印度一项基于临床的横断面描述性研究。

背景：糖尿病是一种全球性流行病，越来越多的未确诊个体，特别是2型糖尿病（T2DM）患者。然而，关于印度drug-naïve患者治疗延误的数据有限。本研究旨在确定drug-naïve患者治疗延误的发生率和自诊断以来寻求替代治疗的顺序。材料和方法：这项横断面、多中心、观察性研究于2023年10月至2024年4月在孟买的10个初级和二级医疗机构进行。被诊断为2型糖尿病的成年人，无论性别，只要是drug-naïve，都被纳入研究对象。患者的人口统计数据、合并症、当前用药和病史记录在电子病例报告表格中并进行分析。结果：在625例入组患者中，591例完成了研究。患者平均年龄46.7岁。男性患者占54.1%。总体而言，57%的患者没有治疗延迟，而43%的患者延迟≥3个月。治疗延迟≥3个月的患者使用替代/传统药物（56.0%），其中56.7%的患者首选阿育吠陀。结论：该研究表明在印度drug-naïve患者中有相当大的治疗延误。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Journal of the Association of Physicians of India Medicine-Medicine (all)

CiteScore

0.80

自引率

0.00%

发文量

509